Wolves in White Coats: How Hospitals Profited from Turning Children into Lifelong Medical Patients

On August 13, 2026, HHS released Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of “Gender Medicine.” The commissioned report, drawing on nationwide insurance claims data, hospital records, peer-reviewed literature, whistleblower accounts, and interviews with patients and parents, documents how more than 225 hospitals and health systems built pediatric gender programs. These programs created what the report calls “captive patients”—healthy young people placed on puberty blockers, cross-sex hormones, and surgeries that require ongoing, high-cost medical management for life.

The Money Trail

All-payer claims data show nearly $120 million in billed charges for sex-rejecting procedures on minors since 2019. That figure includes more than 5,500 surgical procedures and 8,500 courses of hormones or puberty blockers. Lifetime costs for a single patient can range from $25,000–$75,000 without surgery and approach $170,000 when surgeries are included. Individual institutions stand out: Mount Sinai Medical Center in New York billed more than $8.2 million and Boston Children’s Hospital more than $6.5 million between 2019 and 2023 alone.

Pediatrics is traditionally a low-margin specialty. Gender clinics changed the economics. Instead of episodic care for ear infections or broken bones, these programs generate recurring revenue: regular endocrinology visits every three to six months, laboratory monitoring, bone-density scans, prescriptions, mental-health sessions, and eventual surgical referrals. Once a child starts blockers or hormones, the hospital has a patient for decades.

Billing Codes That Raise Red Flags

The report’s most concrete findings concern insurance coding. Between 2015 and 2025, public and private insurers were billed approximately $50 million for puberty blockers prescribed to patients ages 9–17 under the nonspecific diagnostic code E34.9 (“Endocrine Disorder, Unspecified”). Nearly $11 million more was billed under codes for central precocious puberty for patients ages 13–17—an age at which the diagnosis is, by definition, medically inappropriate.

Gender dysphoria has its own diagnostic codes (F64 series). Using vague or incorrect codes can obscure the true purpose of treatment and secure coverage from plans that exclude or restrict “gender-affirming” interventions. The report notes that such practices may violate CMS coding rules requiring specificity and accuracy, and it raises the possibility of False Claims Act liability. Vice President JD Vance, as chairman of the White House Task Force to Eliminate Fraud, and HHS Secretary Robert F. Kennedy Jr. referred identified hospitals and clinics to the Department of Justice and the HHS Office of Inspector General for investigation.

Human Cost Behind the Numbers

The report includes first-hand accounts from patients and parents that illustrate the human consequences. Common themes appear repeatedly: rapid affirmation without thorough exploration of underlying trauma, autism, social influence, or mental-health issues; pressure on parents who were told their child would suicide without medicalization; limited discussion of sterility, sexual dysfunction, bone-density loss, and other irreversible effects; and the near-absence of structured pathways for those who later sought to stop treatment or detransition.

These stories echo what European systematic reviews, including the UK’s Cass Review, have already documented: weak evidence of long-term benefit and clear evidence of harm. American professional societies—WPATH, the Endocrine Society, the American Academy of Pediatrics, and others—promoted the affirmative model even as the underlying evidence base remained thin. Federal policy under the prior administration further accelerated the expansion through nondiscrimination interpretations, guidance, and coverage requirements.

Accountability and Course Correction

The same week the report landed, HHS finalized a rule ending federal Medicaid and CHIP funding for sex-rejecting procedures (puberty blockers, cross-sex hormones, and surgeries) on minors. The rule takes effect October 13, 2026, with a limited tapering period for those already on hormones. Mental-health services remain covered. Officials framed both the report and the funding cutoff as restoring science, protecting taxpayers, and putting children’s health above ideology and profit.

HHS Secretary Kennedy stated: “Doctors and hospitals must put children’s health ahead of ideology and financial gain.” CMS Administrator Dr. Mehmet Oz added that the agency has a duty to ensure taxpayer dollars are spent lawfully and honestly, especially when children are involved. Assistant Secretary for Health Admiral Brian Christine emphasized the ethical duty to “do no harm” and noted that the medical establishment had created “captive patients.”

Why This Matters

This is not an abstract policy debate. It is about whether American medicine will continue to treat healthy children’s bodies as sites for experimental, high-revenue interventions driven by ideology, or whether it will return to evidence-based care that prioritizes the long-term physical and mental well-being of the young. The Wolves in White Coats report provides the data, the dollar figures, the coding anomalies, and the personal testimonies that make the scale of the problem impossible to ignore.

Parents, state attorneys general, Medicaid Fraud Control Units, and federal investigators now have a roadmap. The question is whether the institutions that built this system will face meaningful accountability—or whether the pattern of protecting the ideology and the revenue stream will continue. For the children already harmed and for those still at risk, the answer cannot wait.

Sources and Citations

1. U.S. Department of Health and Human Services, Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of “Gender Medicine” (August 13, 2026). Full report: https://www.hhs.gov/sites/default/files/hhs-wolves-in-white-coats.pdf
2. HHS Executive Summary of the report: https://www.hhs.gov/sites/default/files/hhs-wolves-white-coats-executive-summary.pdf
3. HHS Press Release, “HHS Releases Report Exposing Fraudulent Insurance Coding for Sex-Rejecting Procedures on Minors” (August 13, 2026): https://health.gov/hhs-releases-report-exposing-fraudulent-insurance-coding-sex-rejecting-procedures-minors
4. HHS Press Release, “HHS Ends Federal Medicaid and CHIP Funding for Sex-Rejecting Procedures for Children and Youth” (August 11, 2026): https://www.hhs.gov/press-room/hhs-ends-medicaid-chip-funding-sex-rejecting-procedures-children.html
5. Federal Register final rule on Medicaid/CHIP prohibition (published August 13, 2026): https://www.federalregister.gov/documents/2026/08/13/2026-16508/medicaid-program-prohibition-on-federal-medicaid-and-childrens-health-insurance-program-funding-for
6. Statements from HHS Secretary Robert F. Kennedy Jr., CMS Administrator Dr. Mehmet Oz, and Assistant Secretary for Health Admiral Brian Christine (contained in the August 13 HHS press release).
7. Related coverage and analysis confirming key figures (Daily Wire, Washington Examiner, Fox News, New York Post, and others reporting on the August 13 release and referrals by Vice President JD Vance).

The full 64-page report and accompanying short-form documentary remain the primary sources for the claims, numbers, and patient accounts summarized above.